Transhepatic Therapies for Metastatic Uveal Melanoma

被引：33
|
作者：
Eschelman, David J. [1 ,2 ,3 ]
Gonsalves, Carin F. [1 ,2 ,3 ]
Sato, Takami [4 ]
机构：
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA 19107 USA
[2] Kimmel Canc Ctr, Div Intervent Radiol, Philadelphia, PA USA
[3] Kimmel Canc Ctr, Dept Radiol, Philadelphia, PA USA
[4] Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA USA
来源：
SEMINARS IN INTERVENTIONAL RADIOLOGY | 2013年 / 30卷 / 01期
关键词：
uveal melanoma; liver metastases; chemoembolization; immunoembolization; radioembolization; HEPATIC ARTERIAL CHEMOEMBOLIZATION; OCULAR MELANOMA; LIVER METASTASES; TRANSARTERIAL IMMUNOEMBOLIZATION; HEPATOCELLULAR-CARCINOMA; MONOSOMY; SURVIVAL; EXPERIENCE; TUMORS; RADIOEMBOLIZATION;
D O I：
10.1055/s-0033-1333652
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Despite successful treatment of the primary tumor, uveal melanoma has a propensity to metastasize to the liver. Prognosis is poor due to the very aggressive nature of these tumors. Because systemic therapies are relatively ineffective and patient survival correlates to disease control in the liver, locoregional therapies provide a means of prolonging survival. We review various techniques including chemoembolization, immunoembolization, radioembolization, arterial fotemustine infusion, and hepatic perfusion for the treatment of liver metastases from uveal melanoma.
引用
收藏
页码：39 / 48
页数：10
相关论文
共 50 条
  • [41] Update on Metastatic Uveal Melanoma: Progress and Challenges
    Spagnolo, Francesco
    Picasso, Virginia
    Spano, Laura
    Tanda, Enrica
    Venzano, Clary
    Queirolo, Paola
    BIODRUGS, 2016, 30 (03) : 161 - 172
  • [42] Phosphoproteomic Analysis of Metastatic and Non-Metastatic Uveal Melanoma
    Jang, Geeng-Fu
    Crabb, Jack
    Hu, Bo
    Willard, Belinda
    Kalirai, Helen
    Singh, Arun
    Coupland, Sarah
    Crabb, John
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [43] Systemic and liver-directed therapies in metastatic uveal melanoma: state-of-the-art and novel perspectives
    Comito, Francesca
    Marchese, Paola Valeria
    Ricci, Angela Dalia
    Tober, Nastassja
    Peterle, Chiara
    Sperandi, Francesca
    Melotti, Barbara
    FUTURE ONCOLOGY, 2021, 17 (33) : 4583 - 4606
  • [44] Treatment of Metastatic Uveal Melanoma: Systematic Review
    Rodriguez-Vidal, Cristina
    Fernandez-Diaz, Daniel
    Fernandez-Marta, Beatriz
    Lago-Baameiro, Nerea
    Pardo, Maria
    Silva, Paula
    Paniagua, Laura
    Jose Blanco-Teijeiro, Maria
    Pineiro, Antonio
    Bande, Manuel
    CANCERS, 2020, 12 (09) : 1 - 22
  • [45] The use of pembrolizumab for the treatment of metastatic uveal melanoma
    Kottschade, Lisa A.
    McWilliams, Robert R.
    Markovic, Svetomir N.
    Block, Matthew S.
    Bisneto, Jose Villasboas
    Pham, Anthony Q.
    Esplin, Brandt L.
    Dronca, Roxana S.
    MELANOMA RESEARCH, 2016, 26 (03) : 300 - 303
  • [46] Multiregional genetic evolution of metastatic uveal melanoma
    Rodriguez, Daniel A.
    Yang, Jessica
    Durante, Michael A.
    Shoushtari, Alexander N.
    Moschos, Stergios J.
    Wrzeszczynski, Kazimierz O.
    Harbour, J. William
    Carvajal, Richard D.
    NPJ GENOMIC MEDICINE, 2021, 6 (01)
  • [47] Metastatic Uveal Melanoma: a Prognostic Model and Nomogram
    Parrozzani, Raffaele
    Valpione, Sara
    Chiarion-Sileni, Vanna
    Kotsafti, Olympia
    Midena, Edoardo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [48] VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans
    Barak, Vivian
    Pe'er, Jacob
    Kalickman, Inna
    Frenkel, Shahar
    CURRENT EYE RESEARCH, 2011, 36 (04) : 386 - 390
  • [49] Uveal melanoma: Tumour phenotype and metastatic potential
    Rennie, IG
    EYE, 1997, 11 (2) : 239 - 242
  • [50] Update on Metastatic Uveal Melanoma: Progress and Challenges
    Francesco Spagnolo
    Virginia Picasso
    Laura Spano
    Enrica Tanda
    Clary Venzano
    Paola Queirolo
    BioDrugs, 2016, 30 : 161 - 172
12345